Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EN
Enveric Biosciences, Inc. Common Stock
ENVB
Mkt Cap
$6.2M
Volume
20.86K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
EN
ENVB
EN
Enveric Biosciences, Inc. Common Stock
ENVB
News
·
Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order
Mkt Cap
$6.2M
Volume
20.86K
Next Earnings
November 13th
Chart
Financials
Earnings
News
About
Insider
Filings
Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order
Enveric Biosciences (NASDAQ: ENVB) surged over 106% in premarket trading following President Trump's executive order directing federal agencies to accelerate approval timelines for psychedelic-based treatments. The administration also committed $50 million to ibogaine research. While momentum is improving with positive MACD signals, the stock remains 47.2% below its 200-day moving average, indicating the rally occurs within a longer-term downtrend.
Benzinga · Apr 20, 2026
12 Health Care Stocks Moving In Monday's After-Market Session
Multiple health care stocks experienced significant price movements during Monday's after-market trading session, with some companies seeing notable gains while others experienced declines.
Benzinga · Sep 29, 2025
Enveric Biosciences, Inc. (ENVB) Stock Falls Amid Market Uptick: What Investors Need to Know
The latest trading day saw Enveric Biosciences, Inc. (ENVB) settling at $0.93, representing a -0.46% change from its previous close.
Zacks Investment Research · May 2, 2024
Enveric Biosciences, Inc. (ENVB) Stock Declines While Market Improves: Some Information for Investors
Enveric Biosciences, Inc. (ENVB) closed the most recent trading day at $0.90, moving -0.56% from the previous trading session.
Zacks Investment Research · Apr 26, 2024
New Strong Buy Stocks for April 17th
BYRN, YMAB, SAND, CORT and ENVB have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2023.
Zacks Investment Research · Apr 17, 2024
What Makes Enveric Biosciences (ENVB) a New Strong Buy Stock
Enveric Biosciences (ENVB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Investment Research · Apr 12, 2024
New Strong Buy Stocks for April 12th
ZUO, INTZ, SIGA, ENVB and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on April 12, 2024.
Zacks Investment Research · Apr 12, 2024
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the J.P. Morgan Retail Roundup investor conference where the company reportedly issued a weak outlook. Ulta Beauty shares dipped 13.7% to $448.08 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ARCA biopharma, Inc. (NASDAQ: ABIO) climbed 108% to $3.5549 after the company and Oruka Therapeutics announced a merger agreement. Kintara Therapeutics, Inc. (NASDAQ: KTRA) shares gained 89% to $0.1906 after the company entered a merger agreement with TuHURA Biosciences. Next Technology Holding Inc. (NASDAQ: NXTT) rose 57.4% to $6.42. Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) shares climbed 39.3% to $5.45. Vanda Pharmaceuticals' Fanapt® received U.S. FDA approval for the acute treatment of Bipolar I Disorder. VivoPower International PLC (NASDAQ: VVPR) shares gained 39% to $8.20 after the company declared a capital management strategy including a stock buyback program of up to $5 million. Next.e.GO N.V. (NASDAQ: EGOX) gained 32.7% to $0.0345. XTI Aerospace, Inc. (NASDAQ: XTIA) rose 32.2% to $4.63. BestGrowthStocks.com issued comprehensive evaluation of XTI Aerospace, Inc. Brooge Energy Limited (NASDAQ: BROG) gained 28.8% to $3.0790. Addex Therapeutics Ltd (NASDAQ: ADXN) rose 24.6% to $16.21 after the company and funds affiliated with Perceptive Advisors announced the launch of Neurosterix. Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH) gained 24.3% to $0.3981 after gaining 13% on Tuesday. LAMF Global Ventures Corp. I (NASDAQ: LGVC) gained 22.7% to $13.21. ViewLAMF Global Ventures Corp. I shareholders approved previously announced business combination with Nuvo Group Ltd. Quhuo Limited (NASDAQ: QH) rose 21.7% to $0.6501 after reporting unaudited financial results for the second half and full year 2023. Destiny Tech100 Inc. (NYSE: DXYZ) gained 21.4% to $25.77. OneMedNet Corporation (NASDAQ: ONMD) gained 21.2% to $0.9600. OneMedNet announced it entered a securities purchase agreement dated Mar. 28 providing up to $4.54 million in funding through private placement ...
Benzinga · Apr 3, 2024
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22. Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction. Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates. National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50. Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...
Benzinga · Mar 19, 2024
Nasdaq Down 100 Points; US Housing Starts Surge In February
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.11% to 38,831.86 while the NASDAQ fell 0.63% to 16,001.30. The S&P 500 also fell, dropping, 0.28% to 5,135.12. Check This Out: Nvidia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday Leading and Lagging Sectors Energy shares rose by 0.4% on Tuesday. In trading on Tuesday, information technology shares fell by 0.8%. Top Headline Housing starts in the U.S. surged 10.7% month-over-month to an annualized rate of 1.521 million in February following a 12.3% decline in January. Equities Trading UP Ontrak, Inc. (NASDAQ: OTRK) shares shot up 153% to $0.4787 ahead of the company's presentation at the 36th Annual Roth Conference. Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) got a boost, surging 97% to $21.00 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. Enveric Biosciences, Inc (NASDAQ:
Benzinga · Mar 19, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
EN
ENVB
Enveric Biosciences, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
ENVB
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any ENVB yet.
Related Tickers
Earnings